Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 32 Schemes (35.03%)
Foreign Institutions
Held by 45 Foreign Institutions (8.52%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
29 Million
(Quarterly Results - Apr 2026)
Net Profit:
-39 Million
Pharmaceuticals & Biotechnology
USD 1,136 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.86
-999,999.00%
3.94






